BGB-11417-101

Active, not recruiting

Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies

Beigene Study ID info

BGB-11417-101

ClinicalTrials.gov ID info

EudraCT Number info

2020-004641-37

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents